Fetal sheep support the development of hematopoietic cells in vivo from human induced pluripotent stem cells
DOI: 10.1016/j.exphem.2020.12.006
Authors: Tomoyuki Abe; Hideki Uosaki; Hiroaki Shibata; Hiromasa Hara; Borjigin Sarentonglaga; Yoshikazu Nagao; Yutaka Hanazono
Step 1: iPSC/ESC maintainance
day 0 ~ 1 (duration missing in database; assumed 1 day)
culture “adherent” human PSC in “Primate ES Cell Medium”. For ECM, use “MEF feeder” at “N/A” “N/A”. Medium should contain factors shown in the following table.
| concentration | unit | |
|---|---|---|
| FGF | 4.0e-6 | g/l |
Ideally, “PSC” should be obtained at the end of culture.
Step 2: mesoderm 1
day 1 ~ 2 (duration missing in database; assumed 1 day)
culture “adherent” human PSC in “unspecified medium”.
Ideally, “mesoderm” should express “BRACHYURY” at the end of culture.
Step 3: mesoderm 2
day 2 ~ 3 (duration missing in database; assumed 1 day)
culture “adherent” human PSC in “unspecified medium”.
Ideally, “hemangioblast” should express “GATA2”, “ETV2”, “KDR”, “PDGFRA” at the end of culture.
Step 4: endothelial 1
day 3 ~ 5
culture “adherent” human PSC in “IMDM” for “2” days. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| horse serum | 8 | % |
| FBS | 8 | % |
| Hydrocortisone | 5.0e-6 | mol/l |
| BMP4 | 2.0e-5 | g/l |
| SCF | 2.0e-5 | g/l |
| IL-3 | 2.0e-5 | g/l |
| IL-6 | 1.0e-5 | g/l |
| VEGF | 2.0e-5 | g/l |
| FLT3L | 2.0e-5 | g/l |
| TPO | 4.0e-5 | g/l |
Ideally, “HE” should express “CD34”, “KDR”, “PECAM1”, “CDH5”, “TIE2” at the end of culture.